Figure 3From: 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension Recommended combination therapy, thick lines; preferred combination, thin line; feasible combination. ARB angiotensin receptor blocker, ACE angiotensin-converting enzyme.Back to article page